What is the Org number of IMMUVERA THERAPEUTICS AS?

IMMUVERA THERAPEUTICS AS is registered with Brønnøysundsregistrene under Org 926109553.

What is the revenue of IMMUVERA THERAPEUTICS AS?

IMMUVERA THERAPEUTICS AS reported revenue of NOK 220K in 2024.

How many employees does IMMUVERA THERAPEUTICS AS have?

IMMUVERA THERAPEUTICS AS employs 5 people as of the latest annual report.

Who is the CEO of IMMUVERA THERAPEUTICS AS?

Christoffer James Falchenberg is Chief Executive Officer of IMMUVERA THERAPEUTICS AS, in role since 2021.

Who is the chairman of IMMUVERA THERAPEUTICS AS?

Marcus Sahlin Pettersen chairs the board of IMMUVERA THERAPEUTICS AS, in role since 2023.

Where is IMMUVERA THERAPEUTICS AS headquartered?

IMMUVERA THERAPEUTICS AS's registered address is Gaustadalléen 21, 0349 Oslo.

Riskpilot← Back to search

Sign inGet full access

IMMUVERA THERAPEUTICS AS

ASActive

Org 926109553Gaustadalléen 21, 0349 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20205 employees

Overview Financials People & ownership Related companies

Financials

Revenue

NOK millions

EBITDA

NOK millions

Income statement

NOK thousands

Item	2021	2022	2023	2024
Revenue	208	100	772	220
Staff expenses	−1 849	−2 264	−1 184	−1 602
EBITDA	−6 378	−6 056	−4 656	−5 615
Depreciation & amort.	−1	−32	−149	−294
EBIT	−6 380	−6 088	−4 804	−5 909
Net financials	−1	−6	−26	−9
Profit before tax	−6 381	−6 094	−4 830	−5 918
Tax	−0	−0	−0	−0
Net profit	−6 381	−6 094	−4 830	−5 918

Balance sheet

NOK thousands

Item	2021	2022	2023	2024
Total assets	1 914	7 311	13 410	20 556
Equity	−1 382	4 218	12 161	15 817
Long-term debt	0	247	0	2 901
Short-term debt	3 296	2 846	1 249	1 839
Total debt	3 296	3 093	1 249	4 740

Financial ratios

5-year trend

EBITDA margin

-2547.4%

This company

15.8%

Market median

-16223% vs market

20212024

Equity ratio

76.9%

This company

38.2%

Market median

+101% vs market

20212024

Return on equity

-37.4%

This company

18.4%

Market median

-303% vs market

20212024

Net profit margin

-2685.2%

This company

8.1%

Market median

-33251% vs market

20212024

Asset turnover

0.01×

This company

1.12×

Market median

-99% vs market

20212024

Debt / equity

0.30×

This company

0.62×

Market median

+52% vs market

20212024

Annual reports & filings

Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View PDF

IMMUVERA THERAPEUTICS AS

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on IMMUVERA THERAPEUTICS AS

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on IMMUVERA THERAPEUTICS AS